Persivia Completes $107M Recapitalization to Drive Next Phase of Growth

Backed by Aldrich Capital Partners, company aims to scale innovation and nationwide reach

MCLEAN, Va., April 29, 2025 /PRNewswire/ — Persivia, a leader in AI-driven digital health solutions, today announced the successful completion of a $107 million recapitalization with Aldrich Capital Partners, a growth equity firm focused on high-potential healthcare and technology companies.

With this investment, Persivia is set to accelerate its expansion plans, significantly grow its sales force over the next 12 months, and roll out new AI-powered solutions aimed at driving the next level of operational efficiency and patient management for healthcare organizations nationwide.

“This partnership is about more than just capital,” said Dr. Mansoor Khan, CEO of Persivia. “It’s about launching a national growth strategy and making our platform the first choice for every healthcare organization that wants clean, actionable data and AI-driven tools to support value based care.”

Dr. Fauzia Khan, COO, added, “The Persivia team has done an incredible job of leveraging AI to build an industry leading Digital Health Platform. Starting from product management through engineering, support and account management, each team has gone way beyond the call of duty to deliver excellence. Aldrich’s due diligence showed tremendous client satisfaction as demonstrated by an Industry leading NPS score of 83.”

Persivia’s platform is trusted by leading health systems and payers to streamline workflows, reduce costs, and improve outcomes. Unlike traditional solutions, Persivia offers a single AI-powered platform that delivers clean, governed data across every user and every use case — from value-based care to population health, quality improvement, and more.

Mirza Baig, Managing Partner at Aldrich Capital Partners, said: “We’re excited to partner with a team that’s already changing how healthcare operates. Our goal is to help Persivia scale faster through targeted acquisitions and partnerships that enhance its capabilities and market presence.”

Ron Zwanziger, founder of Alere Inc and Electra DX and a major investor in Persivia, added: “It gives me tremendous satisfaction to see the Connected Health vision we had to improve outcomes years ago come to fruition in Persivia. When you have such a great team, it doesn’t take hundreds of millions of dollars to lead the industry.”

Covington Associates acted as the exclusive financial advisor to Persivia on the transaction.

About Aldrich Capital Partners

Aldrich Capital Partners is a growth equity firm that invests in technology-driven companies with strong leadership and market momentum. The firm provides capital and hands-on support to help companies scale operations and deliver on their growth potential. Learn more at www.aldrichcap.com.

About Persivia

Persivia delivers an AI-powered platform that helps healthcare organizations work smarter. By unifying clinical, claims, social, and operational data into one intelligent system, Persivia turns complex data into real-time insights that drive decisions, streamline workflows, and improve performance across the board. 

Whether it’s powering value-based care, optimizing risk, improving quality, or managing cost and utilization, Persivia’s platform gives payers and providers the tools to move faster, act earlier, and operate more efficiently.

Headquartered in Marlborough, MA, Persivia supports 200+ hospitals and 12,000+ clinicians nationwide. Learn more at www.persivia.com.

Mateen Syed
+1 (703) 349-6774
media@aldrichcap.com

View original content:https://www.prnewswire.com/news-releases/persivia-completes-107m-recapitalization-to-drive-next-phase-of-growth-302440495.html

SOURCE Aldrich Capital Partners

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

24 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

24 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

24 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

24 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

24 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

24 hours ago